Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. (5th November 2018)
- Record Type:
- Journal Article
- Title:
- Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model. (5th November 2018)
- Main Title:
- Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model
- Authors:
- Tavakoli, Fatemeh
Jahanban-Esfahlan, Rana
Seidi, Khaled
Jabbari, Masoumeh
Behzadi, Ramezan
Pilehvar-Soltanahmadi, Younes
Zarghami, Nosratollah - Abstract:
- Abstract: Due to the high rate of drug resistance among malignant melanoma cases, it seems necessary to introduce an efficient pharmaceutical approach to melanoma treatment. For this purpose, Curcumin (Cur) and Chrysin (Chr), two natural anti-cancers, were co-encapsulated in PLGA-PEG nanoparticles (NPs), characterized by DLS, FTIR and FE-SEM and investigated for their effects on MMPs, TIMPs and TERT genes expression in C57B16 mice bearing B16F10 melanoma tumours. The results showed that the expression of MMP-9, MMP-2 and TERT genes were significantly decreased in all treated groups compared to the control. This reduction had the highest amount in CurChr NPs group and then CurChr group for each three genes. Likewise, the expression of TIMP-1 and TIMP-2 genes was significantly increased in all treated groups, compared to the control. Combination groups showed the highest rise in expression of these two genes and the observed increase was greater in nano groups. Moreover, the highest melanoma tumour growth inhibition was detected for CurChr NPs, followed by CurChr = Cur NPs > Cur > Chr NP > Chr. Overall, it is speculated that the nano-combination of Cur and Chr into polymeric NPs with a one-step fabricated co-delivery system may be a promising and convenient approach to improve their efficiency in melanoma cancer therapy.
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 46(2018)Supplement 2
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 46(2018)Supplement 2
- Issue Display:
- Volume 46, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 46
- Issue:
- 2
- Issue Sort Value:
- 2018-0046-0002-0000
- Page Start:
- 75
- Page End:
- 86
- Publication Date:
- 2018-11-05
- Subjects:
- Curcumin -- chrysin -- PLGA-PEG -- nanoparticles -- TERT -- MMPs -- TIMPs -- melanoma
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2018.1452021 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18794.xml